Roles for mitochondrial dysfunction in Alzheimer’s disease


The Scientific Committee of Targeting Mitochondria 2019 Congress invited Prof. Benedict C. Albensi from Max Rady College of Medicine - University of Manitoba, Canada to present his research on "Roles for mitochondrial dysfunction in Alzheimer’s disease" during the 10th Anniversary of Targeting Mitochondria Congress, which will be held in Berlin, Germany, on October 27th – 29th, 2019.

According to Prof. Benedict C. Albensi: Alzheimer’s disease (AD) is thought to be associated with multiple factors, where the greatest risk factor for AD is aging. In addition, much research has focused on amyloid beta and tau pathology as causative factors in AD. However, new data involving brain metabolic activity, proposes that altered mitochondria are a major force behind the development of AD. Understanding mitochondrial dysfunction and targeting mitochondrial bioenergetics could be a novel treatment approach holding great promise for preventing or treating AD.

For more information about Targeting Mitochondria 2019: